The 3-D structure of HIV-1 proteinase and the design of antiviral agents for the treatment of AIDS.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  TIBS -Trends in Biochemical Sciences. Regular ed

• Publication date

  1990-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0968-0004(90)90280-OPMID 2278102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• X-ray analyses of aspartic proteinases. The three-dimensional structure at 2.1 A resolution of endothiapepsin.

  1994cited by this paper
• Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution.

  1991cited by this paper
• The active site of aspartic proteinases

  1991cited by this paper
• In vitro inhibition of HIV‐1 proteinase by cerulenin

  1990cited by this paper
• A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.

  1990cited by this paper
• Hydroxyethylamine analogues of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease.

  1990cited by this paper
• Rational design of peptide-based HIV proteinase inhibitors.

  1990cited by this paper
• A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.

  1990cited by this paper
• Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.

  1990cited by this paper
• Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

  1990cited by this paper
• Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.

  1990cited by this paper
• Retroviral proteinases. A second front against AIDS.

  1989cited by this paper
• Crystal structure of a retroviral protease proves relationship to aspartic protease family

  1989cited by this paper
• X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes

  1989cited by this paper
• Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

  1989cited by this paper
• A second front against AIDS

  1989cited by this paper
• Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.

  1989cited by this paper
• Synthetic non-peptide inhibitors of HIV protease.

  1989cited by this paper
• Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors.

  1989cited by this paper
• Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity

  1989cited by this paper
• The preparation and biochemical characterization of intact capsids of equine infectious anemia virus.

  1989cited by this paper
• Effective blocking of HIV‐1 proteinase activity by characteristic inhibitors of aspartic proteinases

  1989cited by this paper
• Crystallization of the aspartylprotease from the human immunodeficiency virus, HIV-1.

  1989cited by this paper
• Crystallizable HIV-1 protease derived from expression of the viral pol gene in Escherichia coli.

  1989cited by this paper
• Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.

  1989cited by this paper
• Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution.

  1989cited by this paper
• Knowledge‐based protein modelling and design

  1988cited by this paper
• 18th Sir Hans Krebs lecture. Knowledge-based protein modelling and design.

  1988cited by this paper
• Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease.

  1988cited by this paper
• Molecular biology of HIV.

  1988cited by this paper
• Active human immunodeficiency virus protease is required for viral infectivity.

  1988cited by this paper
• Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus

  1988cited by this paper
• A structural model for the retroviral proteases

  1987cited by this paper
• On the rational design of renin inhibitors: X-ray studies of aspartic proteinases complexed with transition-state analogues.

  1987cited by this paper
• Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli.

  1987cited by this paper
• HTLV-III gag protein is processed in yeast cells by the virus pol-protease.

  1986cited by this paper
• Three-dimensional structure of the complex of the Rhizopus chinensis carboxyl proteinase and pepstatin at 2.5-A resolution.

  1982cited by this paper
• Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin.

  1982cited by this paper
• Structural evidence for gene duplication in the evolution of the acid proteases

  1978cited by this paper

• HIVGenoPipe: a nextflow pipeline for the detection of HIV-1 drug resistance using a real-time sample-specific reference sequence

  2025cites this paper
• S-adenosyl-l-methionine interaction signatures in methyltransferases

  2023cites this paper
• A Personal History of Using Crystals and Crystallography to Understand Biology and Advanced Drug Discovery

  2020influential citation
• Protein crystallography and drug discovery: recollections of knowledge exchange between academia and industry

  2017influential citation
• Non-infectious in-cell HIV-1 protease assay utilizing translocalization of a fluorescent reporter protein and apoptosis induction

  2015cites this paper
• Insight into the structural similarity between HIV protease and secreted aspartic protease-2 and binding mode analysis of HIV-Candida albicans inhibitors

  2013cites this paper
• Infections lentivirales chez les petits ruminants domestiques : étude des relations hôte-pathogène et application en diagnostic

  2012cites this paper
• Discovery and Development of Tipranavir

  2011cites this paper
• Looking at the proteases from a simple perspective

  2011cites this paper
• The early years of retroviral protease crystal structures.

  2010cites this paper
• Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors.

  2010cites this paper
• Structure-based antivirals for emerging and neglected RNA viruses: an emerging field for medicinal chemistry in academia.

  2010cites this paper
• Structural and functional restraints in the evolution of protein families and superfamilies.

  2009cites this paper
• In silico and in vitro: identifying new drugs.

  2008cites this paper
• Contribution au projet de génomique structurale du virus d'Epstein-Barr : l'Uracile-ADN glycosylase et les enzymes du métabolisme des acides nucléiques

  2006influential citation
• 3D structure and the drug-discovery process

  2005cites this paper
• HIV protease inhibitors: synthesis and activity of N-aryl-N'-hydroxyalkyl hydrazide pseudopeptides.

  2005cites this paper
• Crystal Structures of a Multidrug-Resistant Human Immunodeficiency Virus Type 1 Protease Reveal an Expanded Active-Site Cavity

  2004cites this paper
• Human immunodeficiency virus 1 retropepsin

  2004cites this paper
• Structural Similarities with Cellular Enzymest

  2003cites this paper
• Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease.

  2003cites this paper
• Proteases as drug targets.

  2003cites this paper
• Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors.

  2003cites this paper
• Transferring Groups by Displacement Reactions

  2001cites this paper
• Characterization of two hydrophobic methyl clusters in HIV-1 protease by NMR spin relaxation in solution.

  2001cites this paper
• Two Sulfonamides‐containing Dihydropyrone Derivatives as HIV Protease Inhibitors

  2001cites this paper
• Structural and biochemical features distinguish the foot-and-mouth disease virus leader proteinase from other papain-like enzymes.

  2000cites this paper
• Alternative exon usage of rat septins.

  2000cites this paper
• Synthesis and HIV Protease Inhibitory Activity of New 4‐Hydroxy‐2‐pyrone Derivatives

  2000cites this paper
• Structure Based Prediction of Binding Affinity of Human Immunodeficiency Virus-1 Protease Inhibitors

  1999cites this paper
• Structure-based discovery of Tipranavir disodium (PNU-140690E): a potent, orally bioavailable, nonpeptidic HIV protease inhibitor.

  1999cites this paper
• General protease assay method coupling solid-phase substrate extraction and capillary electrophoresis.

  1998cites this paper
• Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class.

  1998cites this paper
• Fluorinated peptides incorporating a 4-fluoroproline residue as potential inhibitors of HIV protease

  1997cites this paper
• Synthesis of 7-membered cyclic hydroxyguanidines: Novel HIV-1 protease inhibitors

  1997cites this paper
• Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design.

  1997cites this paper
• Synthesis of 2-isoxazoline and alpha-hydroxy ketomethylene dipeptide isosteres.

  1996cites this paper
• Electrospray mass spectrometric evidence for the occurrence of two major variants in native pig pepsin A.

  1996cites this paper
• Structure of the low-affinity penicillin-binding protein 5 PBP5fm in wild-type and highly penicillin-resistant strains of Enterococcus faecium

  1996cites this paper
• Synthesis of 7-membered cyclic oxamides: Novel HIV-1 protease inhibitors

  1996cites this paper
• Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors.

  1996cites this paper
• SYNTHESIS OF WATER SOLUBLE PRODRUG OF DMP323

  1996cites this paper
• Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors.

  1996cites this paper
• Synthesis of 2-isoxazoline and α-hydroxy ketomethylene dipeptide isosteres

  1996cites this paper
• [17] Strategies for characterizing, cloning, and expressing soluble endopeptidases

  1995cites this paper
• Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors.

  1995cites this paper
• Nonpeptidic potent HIV-1 protease inhibitors: (4-hydroxy-6-phenyl-2-oxo-2H- pyran-3-yl)thiomethanes that span P1-P2' subsites in a unique mode of active site binding.

  1995cites this paper
• Synthesis of 8-membered cyclic sulfamides: Novel HIV-1 protease inhibitors

  1995cites this paper
• Targeting HIV-1 protease: a test of drug-design methodologies.

  1995cites this paper
• Approaches to the development of novel inhibitors of hepatitis C virus replication

  1995cites this paper
• Identification of a putative transcription factor in Candida albicans that can complement the mating defect of Saccharomyces cerevisiae ste12 mutants.

  1994cites this paper
• Fluorinated Analogues of the p17/p24 Sequence Incorporating 3-fluoro and 3,3-difluoro Phenylalanines as Potential Inhibitors of HIV Protease

  1994cites this paper
• Characterization of a monoclonal antibody produced in an attempt to mimic the active site of HIV aspartyl protease using haptens based on inhibitor models.

  1994cites this paper
• Effect of pH and nonphysiological salt concentrations on human immunodeficiency virus-1 protease dimerization.

  1994cites this paper
• Structure-based design of HIV protease inhibitors: 4-hydroxycoumarins and 4-hydroxy-2-pyrones as non-peptidic inhibitors.

  1994cites this paper
• Protein structure--based drug design.

  1994cites this paper
• Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors.

  1994cites this paper
• Inhibitors of the protease from human immunodeficiency virus: synthesis, enzyme inhibition, and antiviral activity of a series of compounds containing the dihydroxyethylene transition-state isostere.

  1993cites this paper
• Theoretical studies of relaxation of a monomeric subunit of HIV‐1 protease in water using molecular dynamics

  1993cites this paper
• Inhibitors of Aspartyl Proteinases

  1993cites this paper
• HIV-1 proteinase as structural model of intercellular transport proteins of plant viruses.

  1993cites this paper
• Peptidomimetic HIV protease inhibitors: phosphate prodrugs with improved biological activities.

  1993cites this paper
• Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

  1993cites this paper
• Protein engineering and design. Method and the industrial relevance.

  1993cites this paper
• Amino acids, peptides and proteins

  1993cites this paper
• Reactivity of cysteine residues in the protease from human immunodeficiency virus: identification of a surface-exposed region which affects enzyme function.

  1993cites this paper
• HIV protease-ligand complexesCurrent Opinion in Structural Biology 1993, 3: 868874

  1993cites this paper
• General and Molecular Aspects of Rennets

  1993cites this paper
• The structure and function of the HSV DNA replication proteins: defining novel antiviral targets.

  1993cites this paper
• Characterization of two structurally novel HIV-1 protease inhibitors identified by rational selection.

  1993cites this paper
• Crystallization and preliminary X-ray investigation of recombinant simian immunodeficiency virus proteinase.

  1993cites this paper
• Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes

  1993cites this paper
• Synthesis of homologous peptides using fragment condensation: analogs of an HIV proteinase substrate.

  1992cites this paper
• Flavones are inhibitors of HIV-1 proteinase.

  1992cites this paper
• Non-peptidic anti-AIDS agents: inhibition of HIV-1 proteinase by disulfonates.

  1992cites this paper
• Synthesis of a potential “suicide substrate” of the HIV-1 protease, incorporating A 3-acetoxy-Δ-4,5-(L)-pipecolic acid as proline substitute.

  1992cites this paper
• Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.

  1992cites this paper
• Mutational analysis of the octapeptide sequence motif at the NS1-NS2A cleavage junction of dengue type 4 virus

  1992cites this paper
• Application of crystallography to the design of antiviral agents.

  1992cites this paper
• High-level expression and purification of mature HIV-1 protease in Escherichia coli under control of the araBAD promoter

  1992cites this paper
• Inhibition of HIV-1 proteinase by metal ions.

  1992cites this paper
• Chemical synthesis of a biotinylated derivative of the simian immunodeficiency virus protease. Purification by avidin affinity chromatography and autocatalytic activation.

  1992cites this paper
• Sequence alignment approach to pick up conformationally similar protein fragments.

  1992cites this paper
• The HIV-1 Protease as a Therapeutic Target for AIDS

  1992cites this paper
• The aspartic proteases.

  1992cites this paper
• The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor.

  1991cites this paper
• HIV‐Infektion und AIDS. Biologische Grundlagen und chemotherapeutische Ansätze

  1991cites this paper
• Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity.

  1991cites this paper
• Inhibition of HIV-1 proteinase by non-peptide carboxylates.

  1991cites this paper
• Zinc inhibition of renin and the protease from human immunodeficiency virus type 1.

  1991cites this paper
• A high throughput assay for inhibitors of HIV‐1 protease Screening of microbial metabolites

  1991cites this paper